These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39074444)

  • 1. Prognostic Factors for Chronic Thrombocytopenia in Systemic Lupus Erythematosus with Immune Thrombocytopenia.
    Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Acta Haematol; 2024 Jul; ():1-9. PubMed ID: 39074444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
    Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
    Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
    Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
    Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia.
    Brik-Simon D; Efros O; Levinsky Y; Amarilyo G; Tirosh I; Levy-Mendelovich S; Steinberg-Shemer O; Izraeli S; Yacobovich J; Gilad O
    Pediatr Blood Cancer; 2024 May; 71(5):e30911. PubMed ID: 38348516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
    Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin (IL)-1 family cytokines could differentiate primary immune thrombocytopenia from systemic lupus erythematosus-associated thrombocytopenia.
    Zhan Y; Cheng L; Wu B; Ji L; Chen P; Li F; Cao J; Ke Y; Yuan L; Min Z; Sun L; Chen H; Hua F; Cheng Y
    Ann Transl Med; 2021 Feb; 9(3):222. PubMed ID: 33708849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature platelet levels correlate with disease activity and predict treatment response of thrombocytopenia in lupus patients.
    Hanata N; Shoda H; Kono M; Komai T; Natsumoto B; Tsuchida Y; Tsuchiya H; Nagafuchi Y; Taoka K; Kurokawa M; Fujio K
    Lupus; 2021 Oct; 30(11):1764-1772. PubMed ID: 34304626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of significant relapse and appropriate maintenance therapy strategy in SLE-associated immune thrombocytopenia.
    Li HJ; Zheng YQ; Chen L; Lin SP; Zheng XX
    Ther Adv Chronic Dis; 2023; 14():20406223231160688. PubMed ID: 36969501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.
    Bashyal KP; Shah S; Ghimire C; Balmuri S; Chaudhary P; Karki S; Poudel AK; Pokharel A; Devarkonda V; Hayat S
    Int J Rheumatol; 2024; 2024():6650921. PubMed ID: 38464849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
    Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
    Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
    Zhou EM; Shen H; Wang D; Xu W
    PeerJ; 2024; 12():e17152. PubMed ID: 38666084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements.
    Samuel H; Nardi M; Karpatkin M; Hart D; Belmont M; Karpatkin S
    Br J Haematol; 1999 Jun; 105(4):1086-91. PubMed ID: 10554825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology and clinical characteristics of pregnancy-emerged thrombocytopenia].
    Chen Z; Liang MY; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2011 Nov; 46(11):834-9. PubMed ID: 22333233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of platelet immunity in patients with SLE and with ITP.
    Lazarus AH; Ellis J; Semple JW; Mody M; Crow AR; Freedman J
    Transfus Sci; 2000; 22(1-2):19-27. PubMed ID: 10771375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of laparoscopic splenectomy in thrombocytopenia secondary to systemic lupus erythematosus.
    Zhou J; Wu Z; Zhou Z; Wang Z; Liu Y; Huang XY; Peng B
    Clin Rheumatol; 2013 Aug; 32(8):1131-8. PubMed ID: 23549638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
    Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
    Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases.
    Nakayama K; Tamimoto Y; Nakayama T
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):69-73. PubMed ID: 37718578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years.
    Jung JY; O AR; Kim JK; Park M
    Korean J Pediatr; 2016 Aug; 59(8):335-40. PubMed ID: 27610182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Systemic Lupus Erythematosus (SLE)-Induced Immune Thrombocytopenia Presented With a Subdural Hematoma.
    Asad DM; Tos SM; Khalil OR; Khammash AH; Awesat AA; Barbarawi AM; Isa Assadi MA; Alzaatreh JK; Mohsen M; Qasem A
    Cureus; 2023 Dec; 15(12):e49958. PubMed ID: 38179378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study.
    Wu Q; Zhao MX; Huang XS; Lin CS; Xu Q
    Lupus; 2024 May; 33(6):608-614. PubMed ID: 38518059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.